**Core Concept:** Akathesia is a side effect of dopamine-blocking agents, such as antipsychotics and antidepressants, characterized by restlessness, agitation, and motor hyperactivity. It is a result of striatal dopamine depletion and hypersensitivity of extrapyramidal receptors.

**Why the Correct Answer is Right:** Akathesia is primarily treated by increasing dopamine levels in the striatum to counteract the side effect. Drugs that increase dopamine levels include dopamine agonists like apomorphine, pramipexole, and ropinirole. These drugs directly act on dopamine D2 receptors, thereby increasing dopamine levels and reducing akathesia symptoms.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Antipsychotics):** These are the drugs primarily responsible for causing akathesia, as they block dopamine D2 receptors in the striatum. Using antipsychotics to treat akathesia would not address the root cause but rather exacerbate the condition.

B. **Option B (Antidepressants):** While antidepressants can cause akathesia, they primarily treat depression by enhancing serotonin and norepinephrine levels in the central nervous system. Using antidepressants for akathesia treatment would not address the dopamine depletion issue caused by antipsychotics or dopamine-blocking agents.

C. **Option C (Benzodiazepines):** Benzodiazepines are primarily used to treat anxiety and insomnia by enhancing gamma-aminobutyric acid (GABA) levels and reducing neuronal excitability. Benzodiazepines are not a suitable option for treating akathesia since they do not address dopamine depletion or hypersensitivity of extrapyramidal receptors.

D. **Option D (Muscle relaxants):** Muscle relaxants are used to treat muscle spasms and tension. They do not address the root cause of akathesia, which is dopamine depletion and extrapyramidal receptor hypersensitivity.

**Clinical Pearl:** Akathesia treatment should focus on increasing dopamine levels and addressing extrapyramidal receptors. Dopamine agonists, such as those mentioned, are appropriate choices for treatment, while the wrong options target different neurological pathways and do not address the dopamine depletion and extrapyramidal receptor hypersensitivity associated with akathesia.